Pentoxifylline improves circulatory failure and survival in murine models of endotoxaemia

European Journal of Pharmacology

Volumn 373, Issue 1, 1999, Pages 41-49

  Wu, Chin Chen ^a   Liao, Mei Hui ^a   Chen, Shiu Jen ^a   Yen, Mao Hsiung ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Lipopolysaccharide; Mortality; Nitric oxide (NO); Pentoxifylline; TNF (tumour necrosis factor )

Indexed keywords

ESCHERICHIA COLI ENDOTOXIN; METHYLXANTHINE DERIVATIVE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NORADRENALIN; PENTOXIFYLLINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; HEART ARREST; HEART RATE; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SHOCK; SURVIVAL; THORACIC AORTA;

ANESTHESIA; ANIMALS; AORTA, THORACIC; BLOOD CIRCULATION; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DISEASE MODELS, ANIMAL; ENDOTOXEMIA; HEART RATE; LIPOPOLYSACCHARIDES; LUNG; MALE; MICE; MUSCLE CONTRACTION; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; NOREPINEPHRINE; PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITORS; RATS; RATS, INBRED WKY; SURVIVAL RATE; TUMOR NECROSIS FACTOR-ALPHA; VASOCONSTRICTOR AGENTS;

EID: 0032981604     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00265-4     Document Type: Article

References (38)

1. Berkenboom G., Fang Z.Y., Unger P., Goldman M., Fontaine J. Endothelium-dependent effects of pentoxifylline in rat aorta. Eur. J. Pharmacol. 193:1991;81-86.
2. Beutler B., Cerami A. The biology of cachectin/TNFα: a primary mediator of the host response. Annu. Rev. Immunol. 7:1989;625-655.
3. Busse R., Mulsch A. Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Lett. 275:1990;87-90.
4. Crutchley D.J., Conanan L.B., Que B.G. Effects of prostacyclin analogs on the synthesis of tissue factor, tumour necrosis factor-α and interleukin-1β in human monocytic THP-1 cells. J. Pharmacol. Exp. Ther. 271:1994;446-451.
5. Fischer W., Schudt C., Wendel A. Protection by phosphodiesterase inhibitors against endotoxin-induced liver injury in galactosamine-sensitized mice. Biochem. Pharmacol. 45:1993;2399-2404.
6. Fleming I., Gray G.A., Julou-Schaeffer G., Parratt J.R., Stoclet J.C. Incubation with endotoxin activates the L-arginine pathway in vascular tissue. Biochem. Biophys. Res. Commun. 171:1990;562-568.
7. Gray G.A., Julou-Schaeffer G., Qury K., Fleming I., Parratt J.R., Stoclet J.C. An L-arginine-derived factor mediates endotoxin-induced vascular hyposensitivity to calcium. Eur. J. Pharmacol. 191:1990;89-92.
8. Ishizaka A., Wu Z.H., Stephens K.E., Harada H., Hogue R.S., O'Hanley P.T., Raffin T.A. Attenuation of acute lung injury in septic guinea pigs by pentoxifylline. Am. Rev. Respir. Dis. 138:1988;376-382.
9. Kaputlu I., Sadan G. Pentoxifylline-induced vasodilatation is not endothelium-dependent in rabbit aorta. J. Basic Clin. Physiol. Pharmacol. 5:1994;295-304.
10. 2 and dexamethasone. J. Hepatol. 7:1988;352-361.
11. G-monomethyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem. Biophys. Res. Commun. 172:1990;1132-1138.
12. Kosaka H., Watanabe M., Yoshihara H., Harada N., Shiga T. Detection of nitric oxide production in lipopolysaccharide-treated rats by ESR using carbon monoxide haemoglobin. Biochem. Biophys. Res. Commun. 184:1992;1119-1124.
13. Kosaka H., Harada N., Watanabe M., Yoshihara H., Katsuki Y., Shiga T. Synergistic stimulation of nitric oxide haemoglobin production in rats by recombinant interleukin 1 and tumour necrosis factor. Biochem. Biophys. Res. Commun. 189:1992;392-397.
14. Mandell G.L. Cytokines, phagocytes, and pentoxifylline. J. Cardiovasc. Pharmacol. 25:1995;S20-S22. Suppl.
15. Michie H.R., Manogue K.R., Springgs D.R., Revhaug A., O'dwyer S., Dinarello C.A., Cerami A., Wolff S.M., Wilmore D.W. Detection of circulating tumour necrosis factor after endotoxin administration. N. Engl. J. Med. 318:1988;1481-1486.
16. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43:1991;109-142.
17. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:1992;3051-3064.
18. Parker M.M., Shelhamer J.H., Natanson C., Alling D., Parillo J.E. Serial haemodynamic patterns in survivors and non-survivors of septic shock in humans. Crit. Care Med. 15:1987;923-929.
19. Parmely M.J., Zhou W., Edwards C.K., Borcherding D.R., Silverstein R., Morrison D.C. Adenosine and related carbocyclic nucleotide analogue selectively inhibit tumour necrosis factor-alpha production and protect mice against endotoxin challenge. J. Immunol. 151:1993;389-396.
20. Parratt, J.R., 1989. Alterations in vascular reactivity in sepsis and endotoxaemia. In: Vincent, J.L. (Ed.), Update in Intensive Care and Emergency Medicine. Springer, Berlin, pp. 299-308.
21. Rees D.D., Cellek S., Palmer R.M.J., Moncada S. Dexamethasone prevents the induction of a nitric oxide synthase and the associated effects on the vascular tone: an insight into endotoxic shock. Biochem. Biophys. Res. Commun. 173:1990;541-547.
22. Semmler J., Gebert U., Eisenhut T., Moeller J., Schoenharting M.M., Allera A., Endres S. Xanthine derivatives: comparison between suppression of tumour necrosis factor-alpha production and inhibition of cAMP phosphodiesterase activity. Immunology. 78:1993;520-525.
23. Sessler C.N., Bloomfield G.L., Fowler A.A. III Current concepts of sepsis and acute lung injury. Clin. Chest Med. 17:1996;213-235.
24. Stoclet J.C., Fleming I., Gray G., Julou-Schaeffer G., Schneider F., Schott C., Schott C., Parratt J.R. Nitric oxide and endotoxaemia. Circulation. 87:1993;V77-V80. Suppl. V.
25. Strieter R.M., Remick D.G., Ward P.A., Spengler R.N., Lynch J.P. III, Larrick J., Kunkel S.L. Cellular and molecular regulation of tumour necrosis factor-alpha production by pentoxifylline. Biochem. Biophys. Res. Commun. 155:1988;1230-1236.
26. Stuehr D., Marletta M. Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc. Natl. Acad. Sci. U.S.A. 82:1985;7738-7742.
27. Szabo C., Mitchell J.A., Thiemermann C., Vane J.R. Nitric oxide mediated hyporeactivity to noradrenaline precedes nitric oxide synthase induction in endotoxin shock. Br. J. Pharmacol. 108:1993;786-792.
28. Thiemermann C. The role of the L-arginine: nitric oxide pathway in circulatory shock. Adv. Pharmacol. 28:1994;45-79.
29. Thiemermann C., Vane J.R. Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo. Eur. J. Pharmacol. 182:1990;591-595.
30. Thiemermann C., Wu C.C., Szabo C., Perretti M., Vane J.R. Role of tumour necrosis factor in the induction of nitric oxide synthase in a rat model of endotoxin shock. Br. J. Pharmacol. 110:1993;177-182.
31. Trajkovic V., Bodovinac V., Popadic D., Hadzic O., Stojkovic M.M. Cell-specific effects of pentoxifylline on nitric oxide production and inducible nitric oxide synthase mRNA expression. J. Immunol. 92:1997;402-406.
32. Wang Q., Jacobs J., De Leo J., Kruszyna H., Kruszyna R., Smith R., Wilcox D. Nitric oxide haemoglobin in mice and rats in endotoxic shock. Life Sci. 49:1991;55-60.
33. Welsh C.H., Lien D., Worthen G.S., Weil J.V. Pentoxifylline decreases endotoxin-induced pulmonary neutrophil sequestration and extravascular protein accumulation in the dog. Am. Rev. Respir. Dis. 138:1988;1106-1114.
34. Wray G.M., Millar C.G., Hinds C.J., Thiemermann C. Selective inhibition of the activity of inducible nitric oxide synthase prevents the circulatory failure, but not the organ injury/dysfunction, caused by endotoxin. Shock. 9:1998;329-335.
35. Wu C.C., Yen M.H. Beneficial effects of dantrolene on lipopolysaccharide-induced haemodynamic alterations in rats and mortality in mice. Eur. J. Pharmacol. 327:1997;17-24.
36. Wu C.C., Hong H.J., Chou T.Z., Ding Y.A., Yen M.H. Evidence for inducible nitric oxide synthase in spontaneously hypertensive rats. Biochem. Biophys. Res. Commun. 228:1996;459-466.
37. Zabel P., Wolter D.T., Schonharting M.M., Schade U.F. Oxpentifylline in endotoxaemia. Lancet. 334:1989;1474-1477.
38. Zabel P., Schade F.U., Schlaak M. Inhibition of endogenous TNF formation by pentoxifylline. Immunobiology. 187:1993;447-463.